Need Help Paying for Pembrolizumab (Keytruda)? Patient Assistant Programs (PAPs) are designed so that you still have access to the treatments you need, in any financial circumstance. Learn more about the manufacturer’s patient assistance program and other options here.
Full Answer
What is the Merck access program for Keytruda® (pembrolizumab)?
The Merck Access Program for KEYTRUDA® (pembrolizumab) The Merck Access Program can help answer questions about access and support for KEYTRUDA® (pembrolizumab). WELCOME TO THE MERCK
What is pembrolizumab used for?
Important Safety Information About KEYTRUDA ® (pembrolizumab) KEYTRUDA is a medicine that may treat certain cancers by working with your immune system. KEYTRUDA can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work.
How do I enroll in the Merck Patient Assistance Program?
Referral to the Merck Patient Assistance Program for eligibility determination (provided through the Merck Patient Assistance Program, Inc.) Product distribution J-Code:J9271 Visit the Coding & Billing Website Use the Electronic Enrollment Form With E-Signature
What is the average cost of a KEYTRUDA treatment?
The list price for each indicated dose of KEYTRUDA when given every 3 weeks is $10,474.08. The list price for each indicated dose of KEYTRUDA when given every 6 weeks is $20,948.16.
What stage of cancer does KEYTRUDA treat?
KEYTRUDA is a prescription medicine used to treat: a kind of skin cancer called melanoma. It may be used in adults and children 12 years of age and older with stage IIB, stage IIC, or stage III melanoma, to help prevent melanoma from coming back after it and lymph nodes that contain cancer have been removed by surgery.
What is the Merck access program?
The Merck Access Program may be able to help answer questions related to insurance coverage and financial assistance options for certain Merck products including questions about: Insurance coverage for patients. Co-pay assistance for eligible patients.
What is the success rate of KEYTRUDA?
KEYTRUDA® (pembrolizumab) Shows Overall Response Rates of 73 to 83 Percent, with Complete Response Rates of 27 to 30 Percent, in Heavily Pre-treated Patients with cHL, in Update to Study KN-087.
How long will KEYTRUDA extend your life?
The average overall survival duration among Keytruda treated patients is now 26.3 months compared to 14.2 months for those treated with chemotherapy. The 36-month overall survival is 43.7% for Keytruda compared to 24.9% for chemotherapy.
Can Stage 4 cancer be cured with immunotherapy?
Immunotherapy is a lung cancer treatment. It does not cure stage 4 lung cancer, but it may help patients live longer.
How do I get free Keytruda?
If you do not have insurance or your insurance does not cover KEYTRUDA, you may be eligible for free product from the Merck Patient Assistance Program if you meet certain financial and medical criteria.
How much does Merck make from Keytruda?
The company reported $5.3 billion in sales of Keytruda, compared with analyst estimates of $4.9 billion.
What is Merck Keytruda?
KEYTRUDA is a humanized monoclonal antibody that blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2, thereby activating T lymphocytes which may affect both tumor cells and healthy cells. Merck has the industry's largest immuno-oncology clinical research program.
How long can you stay on pembrolizumab?
You usually have pembrolizumab every 3 to 6 weeks. It takes about 30 minutes each time you have it. You have pembrolizumab for as long as it works and the side effects are not too bad. You usually have it for up to 2 years, but some people might have treatment for longer than 2 years.
How long does immunotherapy extend life?
Generally, at 2 years, if patients have done well on therapy, and you have 2 years of ongoing disease control, in most patients we are stopping at 2 years and then monitoring them.
Do you take Keytruda for life?
Keytruda is administered as an intravenous infusion every three weeks. The way the cancer, and the patient, responds to treatment, will dictate its duration. But typically, treatments last up to 24 months in patients without disease progression.
Who qualifies for KEYTRUDA?
KEYTRUDA is indicated for the treatment of adult and pediatric patients with refractory primary mediastinal large B-cell lymphoma (PMBCL), or who have relapsed after 2 or more prior lines of therapy. KEYTRUDA is not recommended for treatment of patients with PMBCL who require urgent cytoreductive therapy.
Does KEYTRUDA stop cancer from spreading?
In one study, half of the participants receiving Keytruda and chemotherapy were alive without their cancer spreading, growing, or getting worse at more than 8 months, compared with about 5 months for people treated with the chemotherapy regimen alone.
Is KEYTRUDA a first line treatment?
KEYTRUDA, as a single agent, is indicated for the first-line treatment of patients with NSCLC expressing PD-L1 [tumor proportion score (TPS) ≥1%] as determined by an FDA-approved test, with no EGFR or ALK genomic tumor aberrations, and is stage III where patients are not candidates for surgical resection or definitive ...
How many treatments before KEYTRUDA works?
Keytruda is administered via a 30 min intravenous (IV) infusion every 3-6 weeks. A response to treatment is typically seen within 2-4 months of starting treatment with Keytruda, but the time it takes to work will vary based on cancer type and the stage of disease.
When to use a chemo med for cervical cancer?from keytruda.com
It may be used when your cervical cancer has returned or has spread or cannot be removed by surgery (advanced cervical cancer), and you have received chemotherapy, and it did not work or is no longer working. This use is approved based on how many patients responded to treatment and how long they responded.
How to contact Merck for keytruda?from keytruda.com
Contact The Merck Access Program at 855-257-3932 (or 855-257-7332 for the hearing impaired). The Merck Access Program can help answer questions like:
What is the Merck Access Program?from merck.com
The Merck Access Program may be able to help answer questions related to insurance coverage and financial assistance options for certain Merck products including questions about: Referral to the Merck Patient Assistance Program for eligibility determination (provided through the Merck Patient Assistance Program, Inc.)
How to report side effects of Keytruda?from keytruda.com
Talk to your health care provider for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please read the accompanying Medication Guide for KEYTRUDA and discuss it with your doctor.
How much does Keytruda cost?from keytruda.com
The list price for each indicated dose of KEYTRUDA when given every 3 weeks is $10,067.36. The list price for each indicated dose of KEYTRUDA when given every 6 weeks is $20,134.72.* † The total cost of KEYTRUDA over the course of treatment is the same, whether given every 3 weeks or every 6 weeks. Most people will not pay the list price, although it may have an impact on your out-of-pocket costs. The amount you pay will depend on many factors, including your insurance situation. The information below will help you better estimate what you may pay for your prescription medicine based on your insurance situation and also cover financial assistance that may be available to you. ‡ For the actual out-of-pocket cost of your treatment, talk to your insurance provider, who knows the details of your plan if you have insurance, or contact your oncologist’s office for help.
What is the cancer called when you have tried a treatment and it did not work?from keytruda.com
a kind of cancer called primary mediastinal B-cell lymphoma (PMBCL). It may be used in adults and children when you have tried a treatment and it did not work, or your PMBCL has returned after you received 2 or more types of treatment. a kind of bladder and urinary tract cancer called urothelial carcinoma.
What is the term for a cancer that has returned after 2 treatments?from keytruda.com
your cHL has returned after you received 2 or more types of treatment. a kind of cancer called primary mediastinal B-cell lymphoma (PMBCL). It may be used in adults and children when you have tried a treatment and it did not work, or your PMBCL has returned after you received 2 or more types of treatment.
The Merck Access Program
The Merck Access Program can help answer questions about benefit investigations, billing and coding, co-pay assistance for eligible patients, the prior authorization process, referral to the Merck Patient Assistance Program for eligibility determination (provided through the Merck Patient Assistance Program, Inc), and product distribution.
Eisai Assistance Program
This resource provides information about your patients’ benefits for LENVIMA. Specialists complete a full benefit investigation to understand your patients’ insurance coverage for LENVIMA and, if needed, can also discuss options for financial assistance to help your patients access LENVIMA.
Dose Exchange Program
For assistance with patients that require a dose reduction, please visit EisaiReimbursement.com.
Financial Assistance for LENVIMA
With the LENVIMA $0 Co-Pay Program *, eligible commercially insured patients will pay as little as $0 out-of-pocket for each prescription. Eisai will pay up to a maximum of $40,000 per year to assist with the out-of-pocket costs for LENVIMA.
Accessing LENVIMA
Specialty Pharmacies LENVIMA is available through 6 Specialty Pharmacies—Accredo ®, Biologics, CVS, Onco360 and Optum ® and US Bioservices, that will mail LENVIMA directly to patients.
What is the enrollment form for a patient?
Patient must sign the enrollment form to give the program permission to access their financial information in order to determine eligibility. Patients in need who appear not to qualify should still call. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
Is Keytruda valid with insurance?
Prices are for cash paying customers only and are not valid with insurance plans. This Keytruda price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
When to use a chemo med for cervical cancer?
It may be used when your cervical cancer has returned or has spread or cannot be removed by surgery (advanced cervical cancer), and you have received chemotherapy, and it did not work or is no longer working. This use is approved based on how many patients responded to treatment and how long they responded.
How to contact Merck for keytruda?
Contact The Merck Access Program at 855-257-3932 (or 855-257-7332 for the hearing impaired). The Merck Access Program can help answer questions like:
How much does Keytruda cost?
The list price for each indicated dose of KEYTRUDA when given every 3 weeks is $10,067.36. The list price for each indicated dose of KEYTRUDA when given every 6 weeks is $20,134.72.* † The total cost of KEYTRUDA over the course of treatment is the same, whether given every 3 weeks or every 6 weeks. Most people will not pay the list price, although it may have an impact on your out-of-pocket costs. The amount you pay will depend on many factors, including your insurance situation. The information below will help you better estimate what you may pay for your prescription medicine based on your insurance situation and also cover financial assistance that may be available to you. ‡ For the actual out-of-pocket cost of your treatment, talk to your insurance provider, who knows the details of your plan if you have insurance, or contact your oncologist’s office for help.
What is the cancer called when you have tried a treatment and it did not work?
a kind of cancer called primary mediastinal B-cell lymphoma (PMBCL). It may be used in adults and children when you have tried a treatment and it did not work, or your PMBCL has returned after you received 2 or more types of treatment. a kind of bladder and urinary tract cancer called urothelial carcinoma.
When to use melanoma meds?
It may be used when your melanoma has spread or cannot be removed by surgery (advanced melanoma), or. It may be used to help prevent melanoma from coming back after it and lymph nodes that contain cancer have been removed by surgery. a kind of lung cancer called non–small cell lung cancer (NSCLC).
Can you have chemo with PD L1?
It may be used alone as your first treatment when your lung cancer has not spread outside your chest (stage III) and you cannot have surgery or chemotherapy with radiation, or your NSCLC has spread to other areas of your body (advanced NSCLC), and your tumor tests positive for “ PD-L1 ” and does not have an abnormal “EGFR” or “ALK” gene.
When to use a chemo med for cervical cancer?
It may be used when your cervical cancer has returned or has spread or cannot be removed by surgery (advanced cervical cancer), and you have received chemotherapy, and it did not work or is no longer working. This use is approved based on how many patients responded to treatment and how long they responded.
When to use melanoma meds?
It may be used when your melanoma has spread or cannot be removed by surgery (advanced melanoma), or. It may be used to help prevent melanoma from coming back after it and lymph nodes that contain cancer have been removed by surgery. a kind of lung cancer called non–small cell lung cancer (NSCLC).
Can platinum be used for bladder cancer?
It may be used when your bladder or urinary tract cancer has spread or cannot be removed by surgery (advanced urothelial cancer) and you have received chemotherapy that contains platinum, and it did not work or is no longer working.
Can you have chemo with PD L1?
It may be used alone as your first treatment when your lung cancer has not spread outside your chest (stage III) and you cannot have surgery or chemotherapy with radiation, or your NSCLC has spread to other areas of your body (advanced NSCLC), and your tumor tests positive for “ PD-L1 ” and does not have an abnormal “EGFR” or “ALK” gene.
When to use a chemo med for cervical cancer?from keytruda.com
It may be used when your cervical cancer has returned or has spread or cannot be removed by surgery (advanced cervical cancer), and you have received chemotherapy, and it did not work or is no longer working. This use is approved based on how many patients responded to treatment and how long they responded.
When to use melanoma meds?from keytruda.com
It may be used when your melanoma has spread or cannot be removed by surgery (advanced melanoma), or. It may be used to help prevent melanoma from coming back after it and lymph nodes that contain cancer have been removed by surgery. a kind of lung cancer called non–small cell lung cancer (NSCLC).
What is Merck Access Portal?from merckaccessportal.com
The Merck Access Portal can help answer questions about patient access and support, including insurance coverage for patients, reimbursement, co-pay assistance for eligible, commercially insured patients, benefit investigations, prior authorizations, appeals, and referrals to the Merck Patient Assistance Program for eligibility determination.
What is the term for a cancer that has returned after 2 treatments?from keytruda.com
your cHL has returned after you received 2 or more types of treatment. a kind of cancer called primary mediastinal B-cell lymphoma (PMBCL). It may be used in adults and children when you have tried a treatment and it did not work, or your PMBCL has returned after you received 2 or more types of treatment.
Can you have chemo with PD L1?from keytruda.com
It may be used alone as your first treatment when your lung cancer has not spread outside your chest (stage III) and you cannot have surgery or chemotherapy with radiation, or your NSCLC has spread to other areas of your body (advanced NSCLC), and your tumor tests positive for “ PD-L1 ” and does not have an abnormal “EGFR” or “ALK” gene.
Can TNBC be used for cancer?from keytruda.com
a kind of cancer called triple-negative breast cancer (TNBC). It may be used with chemotherapy medicines when your breast cancer: has returned and cannot be removed by surgery or has spread, and.
Can platinum be used for bladder cancer?from keytruda.com
It may be used when your bladder or urinary tract cancer has spread or cannot be removed by surgery (advanced urothelial cancer) and you have received chemotherapy that contains platinum, and it did not work or is no longer working.
When to use a chemo med for cervical cancer?from keytruda.com
It may be used when your cervical cancer has returned or has spread or cannot be removed by surgery (advanced cervical cancer), and you have received chemotherapy, and it did not work or is no longer working. This use is approved based on how many patients responded to treatment and how long they responded.
How to contact Merck Access?from merckhelps.com
You and your health care provider can call the Merck Access Program at 855-257-3932 to request an enrollment form. The Merck Access Program Representatives are available 8 AM to 8 PM ET, Monday through Friday, to answer questions about the program. Check Your Eligibility.
What is Merck Access Portal?from merckaccessportal.com
The Merck Access Portal can help answer questions about patient access and support, including insurance coverage for patients, reimbursement, co-pay assistance for eligible, commercially insured patients, benefit investigations, prior authorizations, appeals, and referrals to the Merck Patient Assistance Program for eligibility determination.
What is the term for a cancer that has returned after 2 treatments?from keytruda.com
your cHL has returned after you received 2 or more types of treatment. a kind of cancer called primary mediastinal B-cell lymphoma (PMBCL). It may be used in adults and children when you have tried a treatment and it did not work, or your PMBCL has returned after you received 2 or more types of treatment.
When to use melanoma meds?from keytruda.com
It may be used when your melanoma has spread or cannot be removed by surgery (advanced melanoma), or. It may be used to help prevent melanoma from coming back after it and lymph nodes that contain cancer have been removed by surgery. a kind of lung cancer called non–small cell lung cancer (NSCLC).
Can you have chemo with PD L1?from keytruda.com
It may be used alone as your first treatment when your lung cancer has not spread outside your chest (stage III) and you cannot have surgery or chemotherapy with radiation, or your NSCLC has spread to other areas of your body (advanced NSCLC), and your tumor tests positive for “ PD-L1 ” and does not have an abnormal “EGFR” or “ALK” gene.
Can TNBC be used for cancer?from keytruda.com
a kind of cancer called triple-negative breast cancer (TNBC). It may be used with chemotherapy medicines when your breast cancer: has returned and cannot be removed by surgery or has spread, and.
